Pharma 2020: Taxing times ahead

Which path will you take?

We discussed many of the far-reaching changes influencing the pharmaceutical and life sciences industry (Pharma) as it approaches the second decade of the new millennium in the previous four papers in the PricewaterhouseCoopers’ Pharma 2020 series. Our latest report focuses on the resulting opportunities and challenges from a tax perspective.

Contact Name

Marina Sakipi

Contact Phone

+30 210 6874059